ScholarGate
Msaidizi

Linganisha mbinu

Pitia mbinu ulizochagua bega kwa bega; safu zinazotofautiana zinaangaziwa.

Cochrane RoB 2.0×Orodha ya Utafiti Uliochaguliwa kwa Bahati Nasibu wa CASP×
NyanjaMetodolojia ya UtafitiMetodolojia ya Utafiti
FamiliaProcess / pipelineProcess / pipeline
Mwaka wa asili20191993 (updated through 2023)
MwanzilishiJonathan Sterne, Julian Higgins (Cochrane Collaboration)Critical Appraisal Skills Programme (Oxford, UK)
AinaClinician-rated / Research team assessmentClinician-rated / Research team assessment
Chanzo asiliaSterne, J. A., Savović, J., Page, M. J., Elbers, R. G., Blencowe, N. S., Boutron, I., ... & Higgins, J. P. (2019). RoB 2: a revised tool for assessing risk of bias in randomised trials. BMJ, 366, l4898. DOI ↗Critical Appraisal Skills Programme (CASP). (1993, updated). CASP Randomised Controlled Trials Checklist. University of Oxford, UK. www.casp-uk.net link ↗
Majina mbadalaRoB 2.0, RoB 2CASP-RCT, CASP
Zinazohusiana44
MuhtasariRoB 2 is the Cochrane Collaboration's updated methodology for assessing the risk of bias in randomized controlled trials (RCTs). Published in 2019, it replaced the original Cochrane RoB tool with a more structured, transparent approach using signalling questions and domain-based judgments to evaluate five critical sources of bias.The Critical Appraisal Skills Programme (CASP) RCT Checklist is a practical, widely adopted tool developed by the UK-based Critical Appraisal Skills Programme (founded 1993) for assessing the methodological quality and relevance of published randomized controlled trials. Unlike numeric scoring scales, it uses 11 structured questions with yes/no/cannot tell responses to guide critical appraisal in a format accessible to busy clinicians, researchers, and educators.
ScholarGateSeti ya data
  1. v1
  2. 1 Vyanzo
  3. PUBLISHED
  1. v1
  2. 1 Vyanzo
  3. PUBLISHED

Nenda kwenye utafutaji Pakua slaidi

ScholarGateLinganisha mbinu: Cochrane RoB 2.0 · CASP RCT Checklist. Imepatikana 2026-06-20 kutoka https://scholargate.app/sw/compare